DEMONSTRATION DATA·NO PHI
← Panel

James O'Brien

81 M · DOB 1944-06-30 · MRN DEMO-1004
ALLERGY · Iodinated contrast (anaphylaxis)ALLERGY · Aspirin (GI bleed)Complex history4 admissions/12moFall risk
Primary providerDr. Amanda Reyes, MD
NurseBrandon S., RN
Last visit2026-04-05

Active problems

  • ·Ischemic cardiomyopathy (EF 25%)I25.5
  • ·AICD placementZ95.810
  • ·Atrial fibrillationI48.91
  • ·Chronic kidney disease, Stage 4N18.4
  • ·COPDJ44.9
  • ·History of GI bleed (2021)K92.2· History
  • ·OsteoarthritisM19.90

Recent labs

Creatinine
2.4
2026-04-05 · HIGH
eGFR
26
2026-04-05 · LOW
Potassium
5.2
2026-04-05 · HIGH
BNP
1420
2026-04-05 · HIGH
Hemoglobin
10.4
2026-04-05 · LOW

Risk scores

Hf Readmission30Day
67
Mortality Risk90Day
24
Adherence Estimate
80
Guideline Concordance
85

Guideline gaps

  • Sacubitril/valsartan below target dose
    On 24/26 BID. Target is 97/103 BID for max benefit, but renal function limits titration.
    priority · low